Biomarker Discovery in Lung Cancer - Malaysia

NCT06504927 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-07-18

No results posted yet for this study

Summary

This study aims to

1. Identify biomarkers and signatures to differentiate between high-risk and lung cancer patients.
2. Discover blood-based biomarkers that can be used as an adjunct test to imaging diagnosis to improve patient follow-up.

Conditions

Sponsors & Collaborators

  • MiRXES Pte Ltd

    collaborator INDUSTRY
  • University of Malaya

    lead OTHER

Principal Investigators

  • Mau Ern Poh · University of Malaya

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-16
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06504927 on ClinicalTrials.gov